youtube_live
Q3 2026 earnings • released • EPS beat +1.96% • Revenue beat +1.44%
See resultschevron_right
IQV:NYSE
Iqvia Holdings Inc
$267.33
arrow_downward
-2.81%(-7.74) 1D
$267.33
0.00% (0.00)
bedtimeAfter hours
Closed: Oct 30, 4:00:11 PM GMT-4 · USD
search
All symbols
No data
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for IQV...
Open
$274.91
High
$274.91
Low
$263.21
Mkt. cap
44.06B
Avg. vol.
1.53M
Volume
1.15M
P/E ratio
32.47
52-wk high
$284.50
52-wk low
$154.50
EPS
$8.23
Beta
1.17
Shares outstanding
164.80M
No. of employees
95K
Open
$274.91
High
$274.91
Low
$263.21
Mkt. cap
44.06B
Avg. vol.
1.53M
Volume
1.15M
P/E ratio
32.47
52-wk high
$284.50
52-wk low
$154.50
EPS
$8.23
Beta
1.17
Shares outstanding
164.80M
No. of employees
95K
News stories
From web sources and news partners
Yahoo Finance
·
18 hours ago
IQV Q3 deep dive: AI adoption and clinical momentum drive growth, guidance raised
GuruFocus
·
1 day ago
IQV Maintained by TD Cowen -- Price Target Raised to $307
Zacks
·
2 days ago
Here's Why IQVIA Holdings (IQV) is a Strong Momentum Stock
Yahoo Finance
·
2 days ago
IQVIA Holdings, Inc. (IQV) Stock Forecasts
About Iqvia Holdings Inc
CEO-
Employees95K
Founded-
HeadquartersDenver, Colorado, United States
SectorHealth care
Websiteiqvia.com
Analyst ratings
Based on 15 analysts giving stock ratings to IQV in the past 3 months
Strong buy
Buy
13
Hold
2
Sell
0
12-month forecast
Based on 15 Wall Street analysts offering 12 month price targets for IQV in the last 3 months.
Highest
Current $267.33
$346.00 (+29.43%)
Average
$314.14 (+17.51%)
Lowest
$270.00 (+1.00%)
Analyst | Recommendation | Action | Price target | Projected | Date |
|---|---|---|---|---|---|
Unknown Analyst Leerink Partners | Buy | Maintained | $320.00 | +19.7% | 10/29/2026 |
Charles Rhyee TD Cowen | Buy | Maintained | $307.00 | +14.8% | 10/29/2026 |
Shlomo Rosenbaum Stifel Nicolaus | Buy | Maintained | $303.00 | +13.3% | 10/28/2026 |
Jailendra Singh Truist Financial | Buy | Maintained | $346.00 | +29.4% | 10/28/2026 |
Kevin Caliendo UBS | Buy | Maintained | $345.00 | +29.1% | 10/28/2026 |
Elizabeth Anderson CFA Evercore ISI | Buy | Maintained | $310.00 | +16% | 10/28/2026 |
Luke Sergott Barclays | Buy | Maintained | $300.00 | +12.2% | 10/28/2026 |
Ryan Halsted RBC Capital | Buy | Reiterated | $319.00 | +19.3% | 10/27/2026 |
Sean Dodge BMO Capital | Buy | Maintained | $305.00 | +14.1% | 10/27/2026 |
Anne Samuel J.P. Morgan | Buy | Reiterated | $325.00 | +21.6% | 10/28/2026 |
Casey Woodring J.P. Morgan | Buy | Reiterated | $325.00 | +21.6% | 10/28/2026 |
Michael Ryskin Bank of America Securities | Buy | Reiterated | $320.00 | +19.7% | 10/27/2026 |
Eric Coldwell Robert W. Baird | Buy | Maintained | $328.00 | +22.7% | 10/27/2026 |
David Larsen BTIG | Hold | Reiterated | - | - | 10/27/2026 |
Avantika Dhabaria Bank of America Securities | Buy | Maintained | $305.00 | +14.1% | 10/09/2026 |
Ann Hynes Mizuho Securities | Buy | Maintained | $300.00 | +12.2% | 10/07/2026 |
Kallum Titchmarsh Morgan Stanley | Hold | Reiterated | $270.00 | +1% | 09/17/2026 |
Unknown Analyst Jefferies | Buy | Maintained | $290.00 | +8.5% | 07/29/2026 |
Jared Haase William Blair | Buy | Reiterated | - | - | 07/28/2026 |
Sidharth Sahoo HSBC | Buy | Maintained | $240.00 | -10.2% | 07/06/2026 |
David Toung Argus Research | Buy | Maintained | - | - | 05/29/2026 |
Max Smock William Blair | Buy | Reiterated | - | - | 05/05/2026 |
Patrick B Donnelly Citi | Hold | Reiterated | $200.00 | -25.2% | 04/07/2026 |
David Windley Jefferies | Buy | Maintained | $255.00 | -4.6% | 02/06/2026 |
Dan Leonard UBS | Buy | Maintained | $240.00 | -10.2% | 02/06/2026 |
Last report
Oct 27, 2026
Fiscal period
Q3 2026
- Normalized EPS / Est. (USD)
- GAAP EPS / Est. (USD)
$3.34 / $3.28
+1.96%beat
arrow_upward
Revenue / Est. (USD)
4.43B / 4.37B
+1.44%beat
arrow_upward
Fiscal Q3 2026 earnings call
youtube_liveWaiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
- Quarterly
- Annual
All values in USD | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|
Revenue | 4.36B | 4.15B | 4.37B | 4.43B |
Cost of goods sold | 2.93B | 2.80B | 2.93B | 2.93B |
Cost of revenue | 2.93B | 2.80B | 2.93B | 2.93B |
Research and development expenses | - | - | - | - |
Total research and development expenses | - | - | - | - |
Selling, general, and admin expenses | 457.00M | 502.00M | 574.00M | 569.00M |
Operating expense | 774.00M | 790.00M | 866.00M | 890.00M |
Total operating expenses | 3.70B | 3.59B | 3.80B | 3.82B |
Operating income | 662.00M | 565.00M | 569.00M | 608.00M |
Other non operating income | 21.00M | -5.00M | -12.00M | 5.00M |
EBT including unusual items | 573.00M | 334.00M | 318.00M | 428.00M |
EBT excluding unusual items | 537.00M | 384.00M | 384.00M | 464.00M |
Income tax expense | 59.00M | 59.00M | 60.00M | 76.00M |
Effective tax rate | 10.30% | 17.66% | 18.87% | 17.76% |
Other operating expenses | - | - | - | - |
Net income | 514.00M | 274.00M | 256.00M | 350.00M |
Net profit margin | 11.78% | 6.60% | 5.86% | 7.90% |
Earnings per share | 3.42 | 2.90 | 3.15 | 3.34 |
Interest and investment income | 11.00M | 10.00M | 7.00M | 12.00M |
Interest expense | -193.00M | -192.00M | -197.00M | -203.00M |
Net interest expenses | -182.00M | -182.00M | -190.00M | -191.00M |
Depreciation and amortization charges | 317.00M | 288.00M | 292.00M | 321.00M |
EBITDA | 979.00M | 853.00M | 861.00M | 929.00M |
Gain or loss from assets sale | - | - | - | - |
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider | Position | Type | Date | Shares | Amount |
|---|---|---|---|---|---|
Page 1
Upcoming events